PHAT
NASDAQ · Pharmaceuticals
Phathom Pharmaceuticals Inc
$7.48
-0.27 (-3.48%)
Open$7.63
Previous Close$7.75
Day High$7.76
Day Low$7.47
52W High$18.31
52W Low$7.59
Volume—
Avg Volume1.31M
Market Cap660.15M
P/E Ratio—
EPS$-1.27
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+578.3% upside
Current
$7.48
$7.48
Target
$50.74
$50.74
$34.41
$50.74 avg
$70.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 182.64M | 173.93M | 162.51M |
| Net Income | -230,764,088 | 52.15M | 46.06M |
| Profit Margin | -126.4% | 30.0% | 28.4% |
| EBITDA | -166,201,556 | 99.13M | 88.44M |
| Free Cash Flow | — | 45.89M | 35.44M |
| Rev Growth | — | -4.6% | -5.1% |
| Debt/Equity | 1.24 | 0.67 | 0.68 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |